State Street Corporation 13D and 13G filings for Enanta Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-22 12:25 pm Sale | 2023-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | STATE STREET CORP STT | 425,640 2.020% | -1,086,552 (-71.85%) | Filing |
| 2023-02-08 1:17 pm Purchase | 2022-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | STATE STREET CORP STT | 1,512,192 7.270% | 385,123 (+34.17%) | Filing |
| 2022-02-11 11:11 am Sale | 2021-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | STATE STREET CORP STT | 1,127,069 5.550% | -46,171 (-3.94%) | Filing |
| 2021-02-09 12:33 pm Purchase | 2020-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | STATE STREET CORP STT | 1,173,240 5.840% | 1,173,240 (New Position) | Filing |